- Dr Garzotto on Aglatimagene Besadenovec Plus Valacyclovir and EBRT in Localized Prostate CancerMark Garzotto, MD, discusses efficacy data with aglatimagene besadenovec plus valacyclovir and EBRT in localized prostate cancer.onclive · 2mo ago↗ source
- Dr Cirstea on Sequencing Considerations in R/R Multiple MyelomaDiana Cirstea, MD, discusses sequencing considerations in relapsed/refractory multiple myeloma in the era of T-cell–redirecting therapies.onclive · 2mo ago↗ source
- Dr Hafron on the FDA Approval of Adjuvant Atezolizumab in MRD+ MIBCJason Hafron, MD, discusses the significance of the FDA approval of adjuvant atezolizumab for MRD+ muscle-invasive bladder cancer.onclive · 2mo ago↗ source